A double-blind, placebo controlled, pilot study to assess the safety and preliminary efficacy of PSD506 in treatment-naive or previously treated (washed out) patients with benign prostatic obstruction and lower urinary tract symptoms
Phase of Trial: Phase IV
Latest Information Update: 17 May 2017
At a glance
- Drugs PSD 506 (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Adverse reactions
- 09 Jul 2007 New trial record.